Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1519689
Disease: Tumor Promotion
Tumor Promotion
0.060 Biomarker phenotype BEFREE The net outcome of SAG-mediated inhibition of c-Jun/AP-1 (pro-tumor promotion) and of p27 (antiproliferation) increased skin hyperplasia, with no apparent effect on apoptosis, as evidenced by increased skin thickness, and increased rate of DNA synthesis, but hardly any apoptosis. 18258608 2008
CUI: C1519689
Disease: Tumor Promotion
Tumor Promotion
0.060 AlteredExpression phenotype BEFREE Activation of activator protein 1 (AP-1) and nuclear factor kappaB (NFkappaB)-dependent transcription is required for tumor promotion in cell culture models and transgenic mice. 17363560 2007
CUI: C1519689
Disease: Tumor Promotion
Tumor Promotion
0.060 Biomarker phenotype BEFREE Inhibitors of AP-1 have been shown to block tumor promotion, transformation, progression and invasion. 16784822 2006
CUI: C1519689
Disease: Tumor Promotion
Tumor Promotion
0.060 Biomarker phenotype BEFREE Overall, these results indicate that MnSOD regulates both cellular redox status and selectively modulates PKCepsilon signaling, thereby delaying AP-1 activation and inhibiting tumor promotion, resulting in reduction of tumors in MnSOD transgenic mice. 11507057 2001
CUI: C1519689
Disease: Tumor Promotion
Tumor Promotion
0.060 Biomarker phenotype BEFREE We conclude that transactivation of a subset of AP-1-dependent genes is required for tumor promotion and may be targeted for cancer prevention. 10449779 1999
CUI: C1519689
Disease: Tumor Promotion
Tumor Promotion
0.060 Biomarker phenotype BEFREE Although the c-jun oncogene is an integral part of the AP-1 transcriptional complex implicated in the process of tumor promotion, its role in the pathogenesis of human tumors is unknown. 8542585 1996